DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

Leukemia. 2011 Jul;25(7):1219-20. doi: 10.1038/leu.2011.82. Epub 2011 Apr 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • DNA (Cytosine-5-)-Methyltransferases / genetics*
  • DNA (Cytosine-5-)-Methyltransferases / physiology
  • DNA Methyltransferase 3A
  • DNA Mutational Analysis
  • Disease Progression
  • Female
  • Heterozygote
  • Humans
  • Leukemia, Myelomonocytic, Chronic / genetics*
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / genetics*
  • Neoplasm Proteins / genetics*
  • Neoplasm Proteins / physiology
  • Primary Myelofibrosis / genetics*
  • Primary Myelofibrosis / pathology
  • Prognosis

Substances

  • DNMT3A protein, human
  • Neoplasm Proteins
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A